These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 31191560

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid.
    Emtenani S, Yuan H, Lin C, Pan M, Hundt JE, Schmidt E, Komorowski L, Stanley JR, Hammers CM.
    Br J Dermatol; 2019 May; 180(5):1099-1106. PubMed ID: 30315657
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. More Severe Erosive Phenotype Despite Lower Circulating Autoantibody Levels in Dipeptidyl Peptidase-4 Inhibitor (DPP4i)-Associated Bullous Pemphigoid: A Retrospective Cohort Study.
    Ständer S, Schmidt E, Zillikens D, Ludwig RJ, Kridin K.
    Am J Clin Dermatol; 2021 Jan; 22(1):117-127. PubMed ID: 33026629
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
    Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann SC, Hellmark T, Sebbag N, Pedicelli C, Sera F, Lacour JP, Wieslander J, Bruckner-Tuderman L, Borradori L, Zambruno G, Hertl M.
    Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180.
    Schmidt E, Skrobek C, Kromminga A, Hashimoto T, Messer G, Bröcker EB, Yancey KB, Zillikens D.
    Br J Dermatol; 2001 Nov; 145(5):778-83. PubMed ID: 11736901
    [Abstract] [Full Text] [Related]

  • 16. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
    Daneshpazhooh M, Ghiasi M, Lajevardi V, Nasiri N, Balighi K, Teimourpour A, Khosravi H, Saeidi V, Mahmoudi H, Chams-Davatchi C.
    Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid.
    Yang B, Wang C, Chen S, Chen X, Lu X, Tian H, Yu M, Zhang D, Shi Z, Zhou G, Zhang F.
    Indian J Dermatol Venereol Leprol; 2012 Apr; 78(6):722-7. PubMed ID: 23075641
    [Abstract] [Full Text] [Related]

  • 19. Reactivity against the BP180 ectodomain in patients with bullous pemphigoid, mucous membrane pemphigoid, multiple sclerosis and Parkinson disease.
    Tegtmeyer J, Romagnuolo M, Hammers CM, Opelka B, Probst C, Komorowski L, Marzano AV, Schmidt E, Goletz S.
    Exp Dermatol; 2024 Jul; 33(7):e15125. PubMed ID: 38946225
    [Abstract] [Full Text] [Related]

  • 20. Anti-BP230 IgE autoantibodies in bullous pemphigoid intraindividually correlate with disease activity.
    Emtenani S, Linnemann BE, Recke A, von Georg A, Goletz S, Schmidt E, van Beek N.
    J Dermatol Sci; 2024 May; 114(2):64-70. PubMed ID: 38582700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.